Cochlear (OTCMKTS:CHEOF – Get Free Report) is expected to be releasing its results before the market opens on Tuesday, August 18th. Analysts expect Cochlear to announce earnings of $1.17 per share and revenue of $811.4390 million for the quarter.
Cochlear Stock Performance
OTCMKTS:CHEOF opened at $88.14 on Tuesday. The stock’s 50 day moving average price is $79.81 and its 200 day moving average price is $110.00. Cochlear has a 52-week low of $64.39 and a 52-week high of $207.71.
About Cochlear
Cochlear (OTCMKTS:CHEOF) is a global medical device company specializing in implantable hearing solutions. The company researches, develops, manufactures and markets cochlear implants, bone conduction hearing devices and acoustic implants designed to improve hearing outcomes for individuals with varying degrees of hearing loss. Cochlear’s product portfolio includes implant processors, electrode arrays and sound processor accessories, supported by proprietary digital signal processing technologies.
Founded in 1981 and headquartered in Sydney, Australia, Cochlear has grown into a multi-national organization with operations in North America, Europe, Asia Pacific and Latin America.
Recommended Stories
- Five stocks we like better than Cochlear
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
